This statement was delivered by the World Heart Federation under agenda item 13.1 – Noncommunicable Diseases – at the Seventy-Eighth World Health Assembly. Honourable Chair, Distinguished Delegates, The World Heart Federation urges bold political action to address cardiovascular disease – the world’s leading, yet most preventable, health threat. WHF calls on Member States to prioritize […]
This statement was delivered by the World Heart Federation under agenda item 17.1 – WHO’s Work in Health Emergencies – at the Seventy-Eighth World Health Assembly. Honourable Chair, Distinguished Delegates, People Living with Noncommunicable Diseases, particularly cardiovascular disease and diabetes, face significant challenges in emergency settings due to strained health systems and disrupted services. […]
GENEVA, 17 May 2025: Stigma and misunderstanding of obesity are preventing people from receiving adequate treatment for the disease, which is increasing the risk of cardiovascular disease (CVD), a new report from the World Heart Federation warns today. The “World Heart Report 2025 – Obesity and Cardiovascular Disease” launched at the World Heart Summit today, […]
Professor Prabhakaran Dorairaj is the Executive Director of the Centre for Chronic Disease Control, New Delhi, a Distinguished Professor of the Public Health Foundation of India and President-Elect of the World Heart Federation. He spoke about receiving the “Excellence Award for Hypertension Risk Reduction,” his belief in a better future addressing a condition that caused […]
Homozygous Familial Hypercholesterolemia (HoFH) is a rare inherited condition that causes dangerously high levels of LDL cholesterol from birth, leading to severe cardiovascular complications and early mortality. Despite affecting approximately 1 in 300,000 people worldwide, fewer than 5% of individuals with HoFH receive an accurate and timely diagnosis. Without intervention, children with HoFH often show […]
Today is #PulmonaryHypertensionDay, a moment to raise awareness about pulmonary hypertension (PH). Because its early symptoms, including shortness of breath, chest pain, and dizziness, are frequently misunderstood, PH is frequently diagnosed only in advanced stages. PH, wherein the arteries carrying blood to the lungs develop increased blood pressure, affects both the lungs and the heart. […]
Pulmonary hypertension is a life-altering condition that often goes undetected until it’s advanced. This Pulmonary Hypertension Day, let’s shine a light on this silent disease, support early diagnosis, and stand with those living with it every day. Awareness saves lives, because breath is not something we can take for granted. To mark Pulmonary Hypertension Day […]
The following statement was prepared by the World Heart Federation in response to the UN Multistakeholder Hearing on NCD’s panel discussion on Reshaping and Strengthening Health Systems and All Forms of Financing to Meet the Needs of People Living With and at Risk of Noncommunicable Diseases and Mental Health Conditions. Distinguished delegates, colleagues and […]
This statement was delivered by Prof. Jagat Narula, President of the World Heart Federation, at the UN Multistakeholder Hearing on NCDs in response to a panel discussion on Tackling the Determinants of Noncommunicable Diseases and Mental Health and Well-Being Through Multisectoral and Effective Governance and Collaborative Action. Distinguished delegates, colleagues and partners, Cardiovascular disease remains […]
A significant step forward in addressing the leading cause of death in Europe took place with the official launch of the MEP Cardiovascular Health Group in the European Parliament. Chaired by MEP Romana Jerković (S&D, Croatia), this cross-party group placed prevention and the tackling of cardiovascular disease (CVD) at the forefront of the EU’s health […]
On 14 April, World Chagas Disease Day, member organizations of the Global Chagas Coalition are sharing and encouraging the adoption of six commitments to their goal of doing more to help eliminate this disease as a public health problem: More access to comprehensive care. More investment in Research & Development (R&D). More support for surveillance, […]